Association of Multiple Medications With the Severity of Dyspepsia
NCT05503940 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2022-09-02
Summary
Dyspepsia is a very common gastrointestinal disease. Some medications, were associated with higher frequent incidences of dyspepsia, including non-steroid anti-inflammatory drugs (NSAIDs), Bisphosphonates, Tetracyclines, et al. Multiple medications were suggested to be strongly relate to adverse drug events (ADEs), adverse drug reactions (ADRs), drug-drug interactions, and drug-disease interactions, which may cause gastrointestinal(GI) dysfunction or injury to the GI mucosa. However, it was unclear whether multiple medications was associated with more severe symptoms of dyspepsia and dyspepsia-based score systems.
Conditions
- Dyspepsia
Sponsors & Collaborators
-
Air Force Military Medical University, China
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-01
- Primary Completion
- 2023-12-31
- Completion
- 2024-06-01
Countries
- China
Study Locations
More Related Trials
-
Prevention of Gastric Ulcers
NCT00629512 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose Aspirin
NCT01069939 ·Status: COMPLETED ·Phase: PHASE3
-
Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs
NCT00241553 ·Status: COMPLETED ·Phase: PHASE3
-
Inappropriate Prescribing of Proton-pump Inhibitor is it Associated With the Burden of Comorbidities in Older Patients?
NCT02841852 ·Status: COMPLETED
-
Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers
NCT02551744 ·Status: COMPLETED ·Phase: NA
-
Effect of Daily Use Proton Pump Inhibitors for One Month on Kidney Function
NCT03910647 ·Status: UNKNOWN ·Phase: PHASE2
-
Nexium Dyspepsia/AST
NCT00251914 ·Status: COMPLETED ·Phase: PHASE3
-
Esomeprazole or Famotidine in the Management of Aspirin Related Non-Ulcer Dyspepsia
NCT00978159 ·Status: UNKNOWN ·Phase: PHASE4
-
Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/Erosion
NCT00843063 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID
NCT00542789 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Nortriptyline on Abdominal Pain/Discomfort and Quality of Life in Patients With Nonulcer Dyspepsia
NCT00547703 ·Status: TERMINATED ·Phase: NA
-
A Comparison of Two Therapeutic Strategies for the Treatment of Aspirin-associated Peptic Ulcers
NCT01353144 ·Status: COMPLETED ·Phase: PHASE4
-
Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer
NCT00595517 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment Outcomes For Functional Dyspepsia Based On Current International Guidelines In Multi-Ethnic Asian Patients
NCT04918017 ·Status: UNKNOWN ·Phase: PHASE4
-
A Phase 1 Study to Evaluate the Effects of Omeprazole and Famotidine on the Absorption of Telotristat Ethyl in Healthy Subjects
NCT03302845 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-induced Gastric Ulcer
NCT00401752 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Examine the Effect of Omeprazole, Famotidine, and an Acidic Beverage on the Pharmacokinetics of Entinostat in Healthy Adult Subjects
NCT02922933 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province
NCT00339768 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter, Double Blinded, Randomized, Parallel Assignment Study to Demonstrate the Efficacy of DA9601
NCT01912066 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued
NCT00633672 ·Status: COMPLETED ·Phase: PHASE3
-
Itopride in Functional Dyspepsia:a Dose Finding Study
NCT00272103 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Stress Ulcer Prophylaxis of Intravenous Esomeprazole in Chinese Seriously Ill Patients
NCT02157376 ·Status: COMPLETED ·Phase: PHASE3
-
Adherence to Gastro-protection in Non-steroidal Anti-inflammatory Drug (NSAID) Using Patients
NCT00699725 ·Status: COMPLETED
-
Gastric Functions & Proton Pump Inhibitor( PPI) Study
NCT00951431 ·Status: COMPLETED ·Phase: PHASE4
-
Nexium Dyspepsia/AST
NCT00251992 ·Status: COMPLETED ·Phase: PHASE3